SCOPUS 정보 검색 플랫폼

Clinical and Translational Science

Volumn 1, Issue 3, 2008, Pages 188-189

The FDA regulatory process for drug and genetic diagnostic test approvals

(2) Bristow, Michael R a Hiatt, William R b

a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE (United States)

b ARCA Biopharma (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL RESEARCH; DIAGNOSTIC TEST; DRUG APPROVAL; FOOD AND DRUG ADMINISTRATION; GENETIC MARKER; GOVERNMENT REGULATION; HUMAN; PATENT; PATIENT SAFETY; PHARMACOGENETICS; PRIORITY JOURNAL; UNITED STATES;

DIAGNOSTIC TEST APPROVAL; DRUG APPROVAL; GENETIC TESTING; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77953445360 PISSN: 17528054 EISSN: 17528062 Source Type: Journal
DOI: 10.1111/j.1752-8062.2008.00066.x Document Type: Article

Times cited : (1)

References (11)

1
- 77953451505
- Accessed September 10
- The CDER Handbook, New Drug Development and Review Process, http://www.fda.gov/cder/handbook. Accessed September 10, 2008.
- (2008) The CDER Handbook, New Drug Development and Review Process

2
- 77953378627
- Rights to inventions made by nonprofit organizations and small business firms under government grants, contracts, and cooperative agreements
- 37 CFR 401. (Current through July 1, 2007). Text from: Code of Federal Regulations. Accessed October 15
- 37 CFR 401. Rights to inventions made by nonprofit organizations and small business firms under government grants, contracts, and cooperative agreements. (Current through July 1, 2007). Text from: Code of Federal Regulations. Accessed October 15, 2008.
- (2008)

3
- 77953448446
- CDER. Accessed September 10
- CDER. New drug evaluation process, http://www.fda.gov/cder/regulator/ applications/NDA.htm. Accessed September 10, 2008.
- (2008) New Drug Evaluation Process

4
- 77953419466
- U.S. FDA. Accessed September 10
- U.S. FDA. Prescription Drug User Fee Act (PDUFA) Documents, http://www.fda.gov/cder/pdufa/default.htm. Accessed September 10, 2008.
- (2008) Prescription Drug User Fee Act (PDUFA) Documents

5
- 17144391455
- The U.S. Food and Drug Administration Cardio-renal Advisory Panel and the drug approval process
- Roden DM, Temple R. The U.S. Food and Drug Administration Cardio-renal Advisory Panel and the drug approval process. Circulation. 2005; 111: 1697-1702.
- (2005) Circulation , vol.111 , pp. 1697-1702
- Roden, D.M.¹ Temple, R.²

6
- 77953383527
- Draft guidance for the public and FDA staff on convening advisory committee meetings
- U.S. FDA
- U.S. FDA. Draft guidance for the public and FDA staff on convening advisory committee meetings. Fed Regist. 2008;73(151):45455-45456.
- (2008) Fed Regist , vol.73 , Issue.15 , pp. 45455-45456

7
- 33846928249
- BiDil for heart failure in black patients: The U.S. Food and Drug Administration perspective
- Temple R, Stockbridge NL. BiDil for heart failure in black patients: The U.S. Food and Drug Administration perspective. Ann Int Med 2007;146:57-62.
- (2007) Ann Int Med , vol.146 , pp. 57-62
- Temple, R.¹ Stockbridge, N.L.²

8
- 1542333321
- U.S. Accessed October 15
- U.S. FDA. Guidance for industry: Pharmacogenic data submissions, http://www.fda.gov/Cder/guidance/6400fnl.pdf. Accessed October 15, 2008.
- (2008) FDA. Guidance for Industry: Pharmacogenic Data Submissions

9
- 77953370665
- FDA damned if it does, damned if it doesn't
- November 9
- Simons J. FDA damned if it does, damned if it doesn't. Fortune. November 9, 2007.
- (2007) Fortune
- Simons, J.¹

10
- 77953450888
- Drug makers say FDA is slowing new-medicine pipeline
- June 30
- Johnson A, Winslow R. Drug makers say FDA is slowing new-medicine pipeline. Wall Street Journal. June 30, 2008.
- (2008) Wall Street Journal
- Johnson, A.¹ Winslow, R.²

11
- 77953461693
- Leerink Swann/MedaCorp 2008 Regulatory Review, January 16
- Leerink Swann/MedaCorp 2008 Regulatory Review, January 16, 2008.
- (2008)

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.